CAR T-CELL THERAPY
Clinical trials for CAR T-CELL THERAPY explained in plain language.
Never miss a new study
Get alerted when new CAR T-CELL THERAPY trials appear
Sign up with your email to follow new studies for CAR T-CELL THERAPY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New immune cell therapy tested for Tough-to-Treat blood cancer
Disease control Recruiting nowThis early-stage study is testing the safety and initial effectiveness of a new CAR-T cell therapy called A-CAR028 for adults with acute myeloid leukemia (AML) that has returned or not responded to other treatments. The study will enroll up to 20 participants to determine safe do…
Matched conditions: CAR T-CELL THERAPY
Phase: PHASE1 • Sponsor: First Affiliated Hospital of Zhejiang University • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
Engineered immune cells battle aggressive cancer in new trial
Disease control Recruiting nowThis study is testing a personalized cell therapy for adults with a fast-growing type of lymphoma that has come back or hasn't responded to at least two prior treatments. Doctors will collect a patient's own immune cells, genetically modify them to better target the cancer, and i…
Matched conditions: CAR T-CELL THERAPY
Phase: PHASE2 • Sponsor: Miltenyi Biomedicine GmbH • Aim: Disease control
Last updated Mar 27, 2026 12:41 UTC
-
Experimental immune therapy tested for Tough-to-Treat lung cancer
Disease control Recruiting nowThis early-stage study is testing a new CAR-T cell therapy called TC-D101 for people with advanced small cell lung cancer that has returned or stopped responding to standard treatments. The study will enroll 24 patients to determine the safest dose and see if the therapy shows ea…
Matched conditions: CAR T-CELL THERAPY
Phase: EARLY_PHASE1 • Sponsor: TCRCure Biopharma Ltd. • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
Scientists hunt for early warning signs of brain fog after revolutionary cancer treatment
Knowledge-focused Recruiting nowThis study aims to understand and predict which cancer patients might experience brain-related side effects after receiving CAR T-cell therapy. Researchers will use brain scans, memory tests, and blood samples from 36 adult patients to look for early warning signs. The goal is to…
Matched conditions: CAR T-CELL THERAPY
Sponsor: University of California, San Diego • Aim: Knowledge-focused
Last updated Apr 01, 2026 21:41 UTC